STRAUMANN HOLDING AG-REG (QS51.DE) Stock Fundamental Analysis
FRA:QS51 - Deutsche Boerse Ag - CH1175448666 - Common Stock - Currency: EUR
QS51 gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 58 industry peers in the Health Care Equipment & Supplies industry. QS51 has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QS51 is quite expensive at the moment. It does show a decent growth rate. With these ratings, QS51 could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
QS51 had positive earnings in the past year.
In the past year QS51 had a positive cash flow from operations.
Each year in the past 5 years QS51 has been profitable.
Each year in the past 5 years QS51 had a positive operating cash flow.
1.2 Ratios
QS51 has a Return On Assets of 10.73%. This is amongst the best in the industry. QS51 outperforms 87.93% of its industry peers.
QS51's Return On Equity of 19.03% is amongst the best of the industry. QS51 outperforms 84.48% of its industry peers.
Looking at the Return On Invested Capital, with a value of 19.95%, QS51 belongs to the top of the industry, outperforming 98.28% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for QS51 is significantly above the industry average of 8.41%.
The last Return On Invested Capital (19.95%) for QS51 is above the 3 year average (19.58%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.73% | ||
| ROE | 19.03% | ||
| ROIC | 19.95% |
ROA(3y)10.34%
ROA(5y)9.59%
ROE(3y)18.64%
ROE(5y)18%
ROIC(3y)19.58%
ROIC(5y)17.81%
1.3 Margins
With an excellent Profit Margin value of 15.51%, QS51 belongs to the best of the industry, outperforming 84.48% of the companies in the same industry.
In the last couple of years the Profit Margin of QS51 has declined.
The Operating Margin of QS51 (25.97%) is better than 94.83% of its industry peers.
QS51's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 71.40%, QS51 is in the better half of the industry, outperforming 77.59% of the companies in the same industry.
QS51's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.97% | ||
| PM (TTM) | 15.51% | ||
| GM | 71.4% |
OM growth 3Y-1.01%
OM growth 5Y0.13%
PM growth 3Y-7.49%
PM growth 5Y-4.18%
GM growth 3Y-2.13%
GM growth 5Y-1.1%
2. Health
2.1 Basic Checks
QS51 has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for QS51 remains at a similar level compared to 1 year ago.
QS51 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, QS51 has an improved debt to assets ratio.
2.2 Solvency
QS51 has an Altman-Z score of 9.04. This indicates that QS51 is financially healthy and has little risk of bankruptcy at the moment.
QS51 has a better Altman-Z score (9.04) than 96.55% of its industry peers.
QS51 has a debt to FCF ratio of 1.49. This is a very positive value and a sign of high solvency as it would only need 1.49 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.49, QS51 belongs to the best of the industry, outperforming 93.10% of the companies in the same industry.
A Debt/Equity ratio of 0.11 indicates that QS51 is not too dependend on debt financing.
QS51 has a better Debt to Equity ratio (0.11) than 81.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | 9.04 |
ROIC/WACC4.05
WACC4.92%
2.3 Liquidity
QS51 has a Current Ratio of 1.61. This is a normal value and indicates that QS51 is financially healthy and should not expect problems in meeting its short term obligations.
QS51 has a Current ratio (1.61) which is comparable to the rest of the industry.
QS51 has a Quick Ratio of 1.15. This is a normal value and indicates that QS51 is financially healthy and should not expect problems in meeting its short term obligations.
QS51 has a Quick ratio of 1.15. This is comparable to the rest of the industry: QS51 outperforms 56.90% of its industry peers.
QS51 does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.15 |
3. Growth
3.1 Past
The earnings per share for QS51 have decreased by -0.72% in the last year.
QS51 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.26% yearly.
QS51 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.98%.
Measured over the past years, QS51 shows a quite strong growth in Revenue. The Revenue has been growing by 9.42% on average per year.
EPS 1Y (TTM)-0.72%
EPS 3Y-1.14%
EPS 5Y5.26%
EPS Q2Q%-26.32%
Revenue 1Y (TTM)9.98%
Revenue growth 3Y7.39%
Revenue growth 5Y9.42%
Sales Q2Q%8.65%
3.2 Future
The Earnings Per Share is expected to grow by 19.31% on average over the next years. This is quite good.
QS51 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.77% yearly.
EPS Next Y31.67%
EPS Next 2Y22.85%
EPS Next 3Y19.99%
EPS Next 5Y19.31%
Revenue Next Year8.48%
Revenue Next 2Y9.47%
Revenue Next 3Y9.7%
Revenue Next 5Y9.77%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 39.76, which means the current valuation is very expensive for QS51.
QS51's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.35, QS51 is valued quite expensively.
With a Price/Forward Earnings ratio of 30.21, QS51 can be considered very expensive at the moment.
QS51's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.20, QS51 is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.76 | ||
| Fwd PE | 30.21 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QS51 is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as QS51.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 55.07 | ||
| EV/EBITDA | 21.59 |
4.3 Compensation for Growth
QS51's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of QS51 may justify a higher PE ratio.
QS51's earnings are expected to grow with 19.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.26
PEG (5Y)7.55
EPS Next 2Y22.85%
EPS Next 3Y19.99%
5. Dividend
5.1 Amount
With a yearly dividend of 0.87%, QS51 is not a good candidate for dividend investing.
QS51's Dividend Yield is a higher than the industry average which is at 2.19.
Compared to an average S&P500 Dividend Yield of 2.40, QS51's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
5.2 History
The dividend of QS51 is nicely growing with an annual growth rate of 10.12%!
Dividend Growth(5Y)10.12%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
34.88% of the earnings are spent on dividend by QS51. This is a low number and sustainable payout ratio.
The dividend of QS51 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.88%
EPS Next 2Y22.85%
EPS Next 3Y19.99%
FRA:QS51 (5/27/2025, 7:00:00 PM)
116.5
+2.7 (+2.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners37.88%
Inst Owner ChangeN/A
Ins Owners32.73%
Ins Owner ChangeN/A
Market Cap18.58B
Analysts73.57
Price Target143.67 (23.32%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
Yearly Dividend0.91
Dividend Growth(5Y)10.12%
DP34.88%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.76 | ||
| Fwd PE | 30.21 | ||
| P/S | 6.94 | ||
| P/FCF | 55.07 | ||
| P/OCF | 35.96 | ||
| P/B | 8.52 | ||
| P/tB | 15.29 | ||
| EV/EBITDA | 21.59 |
EPS(TTM)2.93
EY2.52%
EPS(NY)3.86
Fwd EY3.31%
FCF(TTM)2.12
FCFY1.82%
OCF(TTM)3.24
OCFY2.78%
SpS16.78
BVpS13.67
TBVpS7.62
PEG (NY)1.26
PEG (5Y)7.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.73% | ||
| ROE | 19.03% | ||
| ROCE | 24.3% | ||
| ROIC | 19.95% | ||
| ROICexc | 24.14% | ||
| ROICexgc | 40.83% | ||
| OM | 25.97% | ||
| PM (TTM) | 15.51% | ||
| GM | 71.4% | ||
| FCFM | 12.61% |
ROA(3y)10.34%
ROA(5y)9.59%
ROE(3y)18.64%
ROE(5y)18%
ROIC(3y)19.58%
ROIC(5y)17.81%
ROICexc(3y)24.47%
ROICexc(5y)23.84%
ROICexgc(3y)42.44%
ROICexgc(5y)41.27%
ROCE(3y)23.86%
ROCE(5y)21.7%
ROICexcg growth 3Y-8.65%
ROICexcg growth 5Y-1.8%
ROICexc growth 3Y-7.31%
ROICexc growth 5Y1.25%
OM growth 3Y-1.01%
OM growth 5Y0.13%
PM growth 3Y-7.49%
PM growth 5Y-4.18%
GM growth 3Y-2.13%
GM growth 5Y-1.1%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.29 | ||
| Cap/Depr | 115.76% | ||
| Cap/Sales | 6.7% | ||
| Interest Coverage | 43.15 | ||
| Cash Conversion | 60.78% | ||
| Profit Quality | 81.28% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.15 | ||
| Altman-Z | 9.04 |
F-Score7
WACC4.92%
ROIC/WACC4.05
Cap/Depr(3y)127.11%
Cap/Depr(5y)116.21%
Cap/Sales(3y)7.81%
Cap/Sales(5y)7.04%
Profit Quality(3y)86.54%
Profit Quality(5y)138.64%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.72%
EPS 3Y-1.14%
EPS 5Y5.26%
EPS Q2Q%-26.32%
EPS Next Y31.67%
EPS Next 2Y22.85%
EPS Next 3Y19.99%
EPS Next 5Y19.31%
Revenue 1Y (TTM)9.98%
Revenue growth 3Y7.39%
Revenue growth 5Y9.42%
Sales Q2Q%8.65%
Revenue Next Year8.48%
Revenue Next 2Y9.47%
Revenue Next 3Y9.7%
Revenue Next 5Y9.77%
EBIT growth 1Y3.25%
EBIT growth 3Y6.31%
EBIT growth 5Y9.56%
EBIT Next Year31.64%
EBIT Next 3Y18.52%
EBIT Next 5Y16.77%
FCF growth 1Y0.35%
FCF growth 3Y-10.44%
FCF growth 5Y6.66%
OCF growth 1Y-4.08%
OCF growth 3Y-4.8%
OCF growth 5Y5.01%